Compounds > paroxetine
Page last updated: 2024-08-23

paroxetine and rofecoxib

paroxetine has been researched along with rofecoxib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bairlein, M; Bräuer, N; Dahllöf, H; Hillig, RC; Klint, J; Laux-Biehlmann, A; Mesch, S; Neagoe, I; Nubbemeyer, R; Puetter, V; Schulz, S; Steinmeyer, A; Ter Laak, A; Werner, S; Zollner, TM1
Doshi, P; Godlee, F1

Other Studies

4 other study(ies) available for paroxetine and rofecoxib

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor
    Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

    Topics: Acetamides; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Discovery; Enzyme Induction; Female; Gene Expression Regulation; Humans; Inflammation; Ligands; Male; Mice; Mice, Inbred C57BL; Pain; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2X4

2019
The wider role of regulatory scientists.
    BMJ (Clinical research ed.), 2017, 04-27, Volume: 357

    Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Data Accuracy; Decision Making; Ethics, Research; Humans; Lactones; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Societies, Scientific; Sulfones; Treatment Outcome; United States; United States Food and Drug Administration

2017